Some of the major names in biotech venture capital have charged their startups tens of millions of dollars in “consulting fees” above the earlier 10 years, successfully using back a small portion of the dollars they invested in a business.
The expenses are generally charged in exchange for selected added products and services — these types of as when a enterprise money company financial loans an experienced executive to a startup to direct the firm by way of its early times. They are considerably extra widespread for undertaking money corporations that fund life science companies than for these that focus on technologies or other sectors, in accordance to venture cash authorities, and can assortment from a couple dollars to tens or hundreds of hundreds for each yr, in accordance to a STAT evaluate of Securities and Exchange Commission filings.
What is it?
STAT+ is STAT’s premium subscription assistance for in-depth biotech, pharma, coverage, and lifetime science coverage and evaluation.
Our award-profitable group covers information on Wall Road, policy developments in Washington, early science breakthroughs and scientific demo benefits, and wellness treatment disruption in Silicon Valley and over and above.
What is integrated?
- Daily reporting and investigation
- The most complete market coverage from a powerhouse crew of reporters
- Subscriber-only newsletters
- Each day newsletters to short you on the most significant market information of the day
- STAT+ Conversations
- Weekly opportunities to interact with our reporters and top business gurus in reside video conversations
- Exclusive marketplace situations
- Quality access to subscriber-only networking occasions all over the state
- The very best reporters in the market
- The most reliable and very well-connected newsroom in the health and fitness treatment marketplace
- And substantially much more
- Exclusive interviews with market leaders, profiles, and high quality resources, like our CRISPR Trackr.